PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sichuan Qianli-beoka Medical Technology Inc.

USPTO PatentsView assignee record - 71 granted patents across 0 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sichuan ranks #4,914 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 0 technology areas.

#4,914
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.4/100)
1.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R4914 · Foreign Corporation #4,914 · 71 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-UNK · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 71 grants
  • TOP-DECILE #4,914/49,997
  • PHOTO-FINISH Schul International
  • CPC-UNK CPC blank
  • INNOV-THIN 35.4/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 8/10 fields

Nearest grant-volume peer: Schul International Co., LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sichuan’s 35.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Sichuan

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sichuan's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Sichuan?

Each dot is one of Sichuan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sichuan’s own 1.0 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Sichuan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 70.971.071.07171.071.071.1 010203040 Granted patents (volume) Avg claims / patent Sekisui Plastics Co., Ltd. - 71, 12.1Sekisui PlasticsSR Technologies, Inc. - 71, 19.23SRStaubli Faverges - 71, 14.96Staubli FavergesSchul International Co., LLC - 71, 20.99Schul Internation…Siemens Gamesa Renewable Energy Innovation & Technology S. L. - 71, 13.42Siemens Gamesa Re…Single Buoy Moorings Inc. - 71, 14.49Single Buoy Moori…Tokitae LLC - 71, 30.21TokitaeTrue Manufacturing Co., Inc. - 71, 18.23True ManufacturingSichuan Qianli-beoka Medical Technology Inc. - 71, 1Sichuan Qianli-be…
Sichuan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sichuan's grants concentrate

Sichuan Qianli-beoka Medical Technology Inc. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2024 (32 grants) versus a trough of 4 in 2022. By volume, Sichuan sits between Sekisui Plastics Co., Ltd. and True Manufacturing Co., Inc..

Sichuan's three-year grant acceleration

Sichuan Qianli-beoka Medical Technology Inc. shows 57 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Sichuan's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Sichuan holds 71 patents at rank #4,916, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Sichuan

By rank, the assignees closest to #4,916 in granted patent volume.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sichuan, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Visible World, LLC 35 Broadband iTV, Inc. 35 Sami Labs Limited 35 Aisin Keikinzoku Co., Ltd. 35

Similar claim depth

Nearest assignees by average claims per patent (1.0 here).

Allied Wheel Components 1.0 avg Tianjin Wanda Tyre Co., Ltd. 1.0 avg Kikkerland Design, Inc. 1.0 avg Sun World International, LLC 1.0 avg

Sichuan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20212022202320242025 6
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Sichuan Qianli-beoka Medical Technology Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 8 11.3%
2022 4 5.6%
2023 21 29.6%
2024 32 45.1%
2025partial year 6 8.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sichuan Qianli-beoka Medical Technology Inc.'s patent record in context - here's where to go next.

  • Ranked #4,914 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Sichuan Qianli-beoka Medical Technology Inc. against Sekisui Plastics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.